Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com//news-release/2024/03/13/2845877/0/en/Travere-Therapeutics-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
https://www.globenewswire.com//news-release/2024/03/11/2843642/0/en/Travere-Therapeutics-Submits-Supplemental-New-Drug-Application-to-the-U-S-Food-and-Drug-Administration-Seeking-Full-Approval-of-FILSPARI-sparsentan-for-the-Treatment-of-IgA-Nephrop.html
https://www.globenewswire.com//news-release/2024/02/26/2835527/0/en/Travere-Therapeutics-to-Present-at-Upcoming-Investor-Conferences.html
https://www.reuters.com/business/healthcare-pharmaceuticals/travere-drug-rare-kidney-condition-recommended-eu-approval-2024-02-23/
https://www.globenewswire.com//news-release/2024/02/15/2830352/0/en/Travere-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results.html
https://www.globenewswire.com//news-release/2024/02/08/2826479/0/en/Travere-Therapeutics-to-Report-Fourth-Quarter-and-Full-Year-2024-Financial-Results.html
https://www.globenewswire.com//news-release/2024/02/01/2822478/0/en/Travere-Therapeutics-to-Present-at-the-Guggenheim-6th-Annual-Biotechnology-Conference.html
https://www.globenewswire.com//news-release/2024/01/25/2817387/0/en/Travere-Therapeutics-Announces-Licensing-Agreement-with-Renalys-Pharma-to-Develop-and-Commercialize-Sparsentan-in-Japan-South-Korea-Taiwan-and-Southeast-Asian-Nations.html
https://www.globenewswire.com//news-release/2024/01/08/2805256/0/en/Travere-Therapeutics-Provides-Corporate-Update-and-2024-Outlook.html
https://www.globenewswire.com//news-release/2024/01/02/2802943/0/en/Travere-Therapeutics-to-Present-at-the-42nd-Annual-J-P-Morgan-Healthcare-Conference.html